# Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)

> **NCT01434381** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 30 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** Pfs25-EPA/Alhydrogel

## Key facts

- **NCT ID:** NCT01434381
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434381, "Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01434381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*